SMA News & Perspectives - August 30, 2018
Aug 30, 2018, 08:44 PM
Testing Mestinon, approved in the U.S. and EU as a first-line treatment for myasthenia gravis, as a treatment for fatigue in SMA.
Testing Mestinon, approved in the U.S. and EU as a first-line treatment for myasthenia gravis, as a treatment for fatigue in SMA.
You can visit our support center if you're having problems.